Paolo Cavazza
Plus aucun poste en cours
Fortune : 11 M $ au 30/04/2024
Historique de carrière de Paolo Cavazza
Anciens postes connus de Paolo Cavazza
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SCICLONE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 27/09/2010 | - |
Statistiques
Internationale
| Etats-Unis | 2 |
Opérationnelle
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
SciClone Pharmaceuticals LLC
 SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology SciClone Pharmaceuticals LLC was engaged in the development of therapeutic treatment for oncology, infectious diseases, and cardiovascular disorders. It was also offering ZADAXIN for the treatment of hepatitis B, hepatitis C, certain cancers, and used as immune system enhancer, and DC Bead which is used for the novel treatment of liver cancer. The company was founded in 1990 and was headquartered in San Mateo, CA. | Health Technology |
- Bourse
- Insiders
- Paolo Cavazza
- Expérience